Clinical Trials Browser

Phase 3 × Vomiting × Thalidomide × Clear all

NCT06017284 2023-11-24

PTCA199-5

Phase 3 Recruiting

Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

NCT02203253 2016-08-24

Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting

Phase 3 Completed

Neoplasms, Vomiting